Page last updated: 2024-10-25

desipramine and Dominant Hereditary Sensory Neuropathy, Type III

desipramine has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Research Excerpts

ExcerptRelevanceReference
"Desipramine-treated subjects had decreased uptake but normal loss of 6-[(18)F]fluorodopamine-derived radioactivity."1.35Cardiac sympathetic hypo-innervation in familial dysautonomia. ( Axelrod, FB; Eldadah, B; Goldstein, DS; Sharabi, Y, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, DS1
Eldadah, B1
Sharabi, Y1
Axelrod, FB1

Other Studies

1 other study available for desipramine and Dominant Hereditary Sensory Neuropathy, Type III

ArticleYear
Cardiac sympathetic hypo-innervation in familial dysautonomia.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2008, Volume: 18, Issue:3

    Topics: Adult; Antidepressive Agents, Tricyclic; Case-Control Studies; Catecholamines; Desipramine; Dopamine

2008